CRO Concept Shares Extend Gains; Yiqiao Shenzhou Jumps 20% to Limit Up
CRO concept shares extended their rally in the afternoon session, with Yiqiao Shenzhou surging 20% to hit the daily limit-up. Yaokang Biologics and Bide Pharmaceutical also reached limit-up earlier, while Haoyuan Pharmaceutical, Boteng Pharmaceutical, and Yaoshi Technology advanced more than 10% each. The gains reflect sustained buying interest in the contract research organization sector.
CRO concept stocks continued to strengthen in afternoon trading. As of press time, Yiqiao Shenzhou rose 20% and hit the limit-up, while Yaokang Biologics and Bide Pharmaceutical had already reached limit-up earlier. Haoyuan Pharmaceutical, Boteng Pharmaceutical, and Yaoshi Technology each gained more than 10%.